Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39801 - 39825 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Etoposide	Approved Investigational	MCM8	84515	downregulated	Etoposide results in decreased expression of MCM8 mRNA	20p12.3	A22582
Etoposide	Approved Investigational	MDM2	4193	upregulated	Etoposide results in increased expression of MDM2 mRNA	12q15	A22582
Etoposide	Approved Investigational	MPZL1	9019	downregulated	Etoposide results in decreased expression of MPZL1 mRNA	1q24.2	A21499
Etoposide	Approved Investigational	MR1	3140	upregulated	Etoposide results in increased expression of MR1 mRNA	1q25.3	A21863
Etoposide	Approved Investigational	MRM2	29960	downregulated	Etoposide results in decreased expression of MRM2 mRNA	7p22.3	A21499
Etoposide	Approved Investigational	MSH6	2956	downregulated	Etoposide results in decreased expression of MSH6 mRNA	2p16.3	A21499
Etoposide	Approved Investigational	MYC	4609	downregulated	Etoposide results in decreased expression of MYC mRNA	8q24.21	A21863
Etoposide	Approved Investigational	MYT1	4661	downregulated	Etoposide results in decreased expression of MYT1 mRNA	20q13.33	A22582
Etoposide	Approved Investigational	NCK2	8440	downregulated	Etoposide results in decreased expression of NCK2 mRNA	2q12.2	A20666
Etoposide	Approved Investigational	NEK2	4751	downregulated	Etoposide results in decreased expression of NEK2 mRNA	1q32.3	A22582
Etoposide	Approved Investigational	NPAS1	4861	upregulated	Etoposide results in increased expression of NPAS1 mRNA	19q13.32	A21863
Etoposide	Approved Investigational	NR1H3	10062	upregulated	Etoposide results in increased expression of NR1H3 mRNA	11p11.2	A22586
Etoposide	Approved Investigational	NRIP1	8204	downregulated	Etoposide results in decreased expression of NRIP1 mRNA	21q11.2-q21.1	A22586
Etoposide	Approved Investigational	PALB2	79728	downregulated	Etoposide results in decreased expression of PALB2 mRNA	16p12.2	A21499
Etoposide	Approved Investigational	PELO	53918	downregulated	Etoposide results in decreased expression of PELO mRNA	5q11.2	A21499
Etoposide	Approved Investigational	PLAU	5328	upregulated	Etoposide results in increased expression of PLAU mRNA	10q22.2	A21863
Etoposide	Approved Investigational	PLK2	10769	upregulated	Etoposide results in increased expression of PLK2 mRNA	5q11.2	A21863
Etoposide	Approved Investigational	PLK3	1263	upregulated	Etoposide results in increased expression of PLK3 mRNA	1p34.1	A20666
Etoposide	Approved Investigational	PMAIP1	5366	upregulated	Etoposide results in increased expression of PMAIP1 mRNA	18q21.32	A22266
Etoposide	Approved Investigational	PPARGC1A	10891	upregulated	Etoposide results in increased expression of PPARGC1A mRNA	4p15.2	A22593
Etoposide	Approved Investigational	PPARGC1B	133522	upregulated	Etoposide results in increased expression of PPARGC1B mRNA	5q32	A22593
Etoposide	Approved Investigational	PPP1R13L	10848	upregulated	Etoposide results in increased expression of PPP1R13L mRNA	19q13.32	A22594
Etoposide	Approved Investigational	PRC1	9055	downregulated	Etoposide results in decreased expression of PRC1 mRNA	15q26.1	A20666
Etoposide	Approved Investigational	PRKAB1	5564	upregulated	Etoposide results in increased expression of PRKAB1 mRNA	12q24.23	A21499
Etoposide	Approved Investigational	PROCR	10544	upregulated	Etoposide results in increased expression of PROCR mRNA	20q11.22	A21863

Displaying entries 39801 - 39825 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability